Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Eating Disorders
What is your pharmacologic approach to binge eating disorder with patients where stimulant medications (i.e. lisdexamfetamine/Vyvanse) are contraindicated or ineffective?
Related Questions
What therapeutic approaches have you found effective for athletes with anorexia nervosa whose eating disorder symptoms are intertwined with sport-driven weight pressures?
What is your approach to GLP-1 agonists as a psychiatrist in patients who are overweight or have eating-related disorders?
How do you navigate requests from your employers to see patients for shorter appointment times or less frequently than you feel is clinically indicated?
How do you decide when to initiate medical workup (e.g., thyroid, B12, infection) in a geriatric patient experiencing new onset or worsening low mood?
How do you talk to patients about psychedelic clinical trials for the treatment of major depressive disorder or PTSD?
What medications would you consider for severe delusional disorder in a patient with RLS worsened by aripiprazole and quetiapine, who refuses clozapine?
In your experience how does the dose of Remeron (mirtazapine) influence side effects like hunger and weight gain?
Do you feel it is within your scope of practice as a psychiatrist to prescribe GLP-1 agonists?
What strategies have you found effective for obtaining insurance approval for xanomeline-tropsium (Cobenfy)?
What trainings or resources have you found most useful in expanding your knowledge of LGBTQ+ mental health?
